Literature DB >> 3164978

Effects of low-dose cranial radiation on growth hormone secretory dynamics and hypothalamic-pituitary function.

G Costin1.   

Abstract

Spontaneous growth hormone (GH) secretory dynamics and hypothalamic-pituitary function were studied in 16 long-term survivors of acute lymphoblastic leukemia who were aged 9 to 15 1/2 years and had been treated with prophylactic central nervous system radiation and combined chemotherapy. At the time of study, the mean height was -1.5 SD score below the mean, less than genetic potential, and significantly less than the mean pretreatment height of -0.25 SD score. Height velocity was subnormal for age and sexual stage in all patients. Two patients had compensated hypothyroidism, and four had evidence of gonadal failure. In 11 patients, the peak GH level after two provocative tests was below 10 micrograms/L, which was consistent with GH deficiency. In ten of 13 patients tested, spontaneous GH secretion determined by a 24-hour GH concentration (GHC), GH pulse amplitude, frequency of GH pulses greater than or equal to 5 micrograms/L, and GH peak during wake and sleep hours was significantly less than in normal height controls. Although in three pubertal patients the 24-hour GHC was within normal limits, the GHC during sleep hours, GH pulse amplitude during 24 hours and sleep hours, and peak GH during wake hours were significantly less than in normal height controls. In all pubertal and in two of the prepubertal patients, the somatomedin C (SmC) level was significantly less than in controls. The 24-hour GHC correlated well with the GHC during sleep, peak-stimulated GH level, gonadal steroid level, and the SmC level, but not with height velocity, dose of radiation, or age at radiation. A significant increase in height velocity and the SmC level was noted in all patients treated with GH. These results indicate that GH deficiency occurs after 18 to 24 Gy of cranial radiation and that the puberty-associated growth spurt may mask the decline in height velocity owing to GH deficiency. In some patients treated with cranial radiation, a subtle dysregulation in spontaneous GH secretion may exist despite a normal GH response to provocative testing.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3164978     DOI: 10.1001/archpedi.1988.02150080053022

Source DB:  PubMed          Journal:  Am J Dis Child        ISSN: 0002-922X


  11 in total

Review 1.  Pediatric brain tumor treatment: growth consequences and their management.

Authors:  Sogol Mostoufi-Moab; Adda Grimberg
Journal:  Pediatr Endocrinol Rev       Date:  2010-09

Review 2.  Hypopituitarism as a consequence of brain tumours and radiotherapy.

Authors:  Ken H Darzy; Stephen M Shalet
Journal:  Pituitary       Date:  2005       Impact factor: 4.107

Review 3.  Hypopituitarism following radiotherapy.

Authors:  Ken H Darzy; Stephen M Shalet
Journal:  Pituitary       Date:  2009       Impact factor: 4.107

4.  Growth and growth hormone in children during and after therapy for acute lymphoblastic leukaemia.

Authors:  M Caruso-Nicoletti; M Mancuso; G Spadaro; S P Dibenedetto; A DiCataldo; G Schiliró
Journal:  Eur J Pediatr       Date:  1993-09       Impact factor: 3.183

5.  Endocrine outcome in children with medulloblastoma treated with 18 Gy of craniospinal radiation therapy.

Authors:  Weizhen Xu; Anna Janss; Roger J Packer; Peter Phillips; Joel Goldwein; Thomas Moshang
Journal:  Neuro Oncol       Date:  2004-04       Impact factor: 12.300

6.  Endocrinological aspects of Langerhans cell histiocytosis complicated with diabetes insipidus.

Authors:  K D Lin; J D Lin; H H Hsu; J H Juang; M J Huang; H S Huang
Journal:  J Endocrinol Invest       Date:  1998 Jul-Aug       Impact factor: 4.256

Review 7.  Radiation-induced hypopituitarism after cancer therapy: who, how and when to test.

Authors:  Ken H Darzy
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2009-02

8.  Comparison of height and weight after 12 vs. 18 Gy cranial radiation therapy in pediatric acute lymphoblastic leukemia (ALL) patients.

Authors:  Albert C Chen; M Fatih Okcu; ZoAnn E Dreyer; Kala Y Kamdar; Rona Y Sonabend; Hilary S Suzawa; Eunji Jo; Arnold C Paulino
Journal:  Adv Radiat Oncol       Date:  2017-02-01

Review 9.  Dual Characters of GH-IGF1 Signaling Pathways in Radiotherapy and Post-radiotherapy Repair of Cancers.

Authors:  Yunyun Cheng; Wanqiao Li; Ruirui Gui; Chunli Wang; Jie Song; Zhaoguo Wang; Xue Wang; Yannan Shen; Zhicheng Wang; Linlin Hao
Journal:  Front Cell Dev Biol       Date:  2021-06-09

10.  Hippocampal volumes in patients exposed to low-dose radiation to the basal brain. A case-control study in long-term survivors from cancer in the head and neck region.

Authors:  Erik Olsson; Carl Eckerström; Gertrud Berg; Magnus Borga; Sven Ekholm; Gudmundur Johannsson; Susanne Ribbelin; Göran Starck; Anna Wysocka; Elisabet Löfdahl; Helge Malmgren
Journal:  Radiat Oncol       Date:  2012-11-29       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.